Skip to main content
SpringerLink
Log in

The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

The relationship between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response (TR) of platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients have been extensively investigated by many studies, but the results were inconsistent and inconclusive. The aim of this meta-analysis was to further explore the predictive value of the GSTP1 and GSTM1 polymorphisms by collecting currently available evidence. Relevant studies were searched in PubMed, Embase, and CNKI. Inclusion criteria were NSCLC patients receiving platinum-based treatment, evaluated GSTP1 A313G or GSTM1 null/present polymorphisms, and TR. Odds ratio (OR) with 95 % confidence interval (CI) was calculated to assess the strength of the associations. Subgroup analysis by race was also conducted to explore the source of heterogeneity. A total of nine studies including 961 NSCLC patients were qualified for analysis. We found that GSTM1 null/present but not GSTP1 A313G polymorphism was associated with platinum-based TR (for GSTM1, null vs present: OR = 1.77, 95% CI = 1.19–2.62). When subgroup analysis by race was done, both GSTP1 and GSTM1 polymorphisms were significantly associated with TR in East-Asian patients, but not in Caucasians. In addition, the heterogeneity disappeared in Asian and Caucasian patients when subgroup analysis by race was done. Our study suggested that the GSTP1 A313G and GSTM1 null/present polymorphisms could predict the treatment response of the platinum-based chemotherapy in NSCLC patients, especially in East-Asian patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. doi:10.3322/caac.20073.

    Article  PubMed  Google Scholar 

  2. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367–80. doi:10.1056/NEJMra0802714.

    Article  CAS  PubMed  Google Scholar 

  3. Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer. Chest. 2006;130(4):1211–9. doi:10.1378/chest.130.4.1211.

    Article  CAS  PubMed  Google Scholar 

  4. Custodio AB, Gonzalez-Larriba JL, Bobokova J, Calles A, Alvarez R, Cuadrado E, et al. Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer. J Thorac Oncol. 2009;4(7):891–910. doi:10.1097/JTO.0b013e3181a4b8fb.

    Article  PubMed  Google Scholar 

  5. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007;33(1):9–23. doi:10.1016/j.ctrv.2006.09.006.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Mannervik B, Danielson UH. Glutathione transferases—structure and catalytic activity. CRC Crit Rev Biochem. 1988;23(3):283–337.

    Article  CAS  PubMed  Google Scholar 

  7. Stewart DJ. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol. 2010;75(3):173–234. doi:10.1016/j.critrevonc.2009.11.006.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Ikeda K, Miura K, Himeno S, Imura N, Naganuma A. Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum. Mol Cell Biochem. 2001;219(1–2):51–6.

    Article  CAS  PubMed  Google Scholar 

  9. Ekhart C, Rodenhuis S, Smits PH, Beijnen JH, Huitema AD. An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment. Cancer Treat Rev. 2009;35(1):18–31. doi:10.1016/j.ctrv.2008.07.003.

    Article  CAS  PubMed  Google Scholar 

  10. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30(6):445–600. doi:10.3109/10409239509083491.

    Article  CAS  PubMed  Google Scholar 

  11. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem. 1994;224(3):893–9.

    Article  CAS  PubMed  Google Scholar 

  12. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207–14.

    Article  CAS  PubMed  Google Scholar 

  13. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–16.

    Article  CAS  PubMed  Google Scholar 

  14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  17. Joerger M, Burgers SA, Baas P, Smit EF, Haitjema TJ, Bard MP, et al. Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study. Cancer. 2012;118(9):2466–75. doi:10.1002/cncr.26562.

    Article  CAS  PubMed  Google Scholar 

  18. Zhang YP, Sheng GF, Liu YP, Xue HP, Ling Y. The relationship of GSTP1 and clinical response to platinum based chemotherapy in advanced non-small cell lung cancer. J Med Theory Practice. 2012;25(24):3003–4.

    Google Scholar 

  19. Li W, Yue W, Zhang L, Zhao X, Ma L, Yang X, et al. Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients. Lung. 2012;190(1):91–8. doi:10.1007/s00408-011-9338-8.

    Article  CAS  PubMed  Google Scholar 

  20. Zhou F, Yu Z, Jiang T, Lv H, Yao R, Liang J. Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients. Swiss Med Wkly. 2011;141:w13275. doi:10.4414/smw.2011.13275.

    PubMed  Google Scholar 

  21. Sun N, Sun X, Chen B, Cheng H, Feng J, Cheng L, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2010;65(3):437–46. doi:10.1007/s00280-009-1046-1.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Yue Z, Xu Q, Xu Y, Dong NN, Zhang Y, Zhu LB, et al. GSTP 1 gene polymorphism and susceptibility as well as chemotherapy sensitivity to non-small cell lung cancer. Chin J Cancer Prev Treat. 2009;16(19):1441–4.

    CAS  Google Scholar 

  23. Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, et al. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer. 2009;10(2):118–23. doi:10.3816/CLC.2009.n.015.

    Article  CAS  PubMed  Google Scholar 

  24. Mao Y, Huang CH, Hua D, Deng JZ, Wei W, Yao Q. The relationshhip between glutathione S-transferase gene polymorphisms and chemotherapy response in NSCLC patients. Shandong Med J. 2007;47(36):68–9.

    CAS  Google Scholar 

  25. Booton R, Ward T, Heighway J, Ashcroft L, Morris J, Thatcher N. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer. J Thorac Oncol. 2006;1(7):679–83.

    Article  PubMed  Google Scholar 

  26. Yin JY, Huang Q, Zhao YC, Zhou HH, Liu ZQ. Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients. PLoS One. 2012;7(6):e38150. doi:10.1371/journal.pone.0038150.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Gong M, Dong W, Shi Z, Xu Y, Ni W, An R. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies. PLoS One. 2012;7(11):e50587. doi:10.1371/journal.pone.0050587.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Guangxi scientific research and technology development projects (Grant No.10124001A-44).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China

    Yanlong Yang & Lei Xian

Authors
  1. Yanlong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Xian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lei Xian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, Y., Xian, L. The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis. Tumor Biol. 35, 6791–6799 (2014). https://doi.org/10.1007/s13277-014-1866-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1866-4

Keywords

Search

Navigation